Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 1.09B | 1.19B | 1.55B | 1.31B | 1.01B | 1.02B |
Gross Profit | 777.10M | 850.10M | 1.06B | 861.10M | 646.10M | 643.50M |
EBITDA | 308.80M | 330.10M | 461.90M | 374.40M | 270.00M | 248.50M |
Net Income | 163.80M | 184.80M | 293.80M | 212.50M | 144.50M | 113.40M |
Balance Sheet | ||||||
Total Assets | 3.37B | 3.37B | 3.21B | 2.99B | 2.78B | 2.79B |
Cash, Cash Equivalents and Short-Term Investments | 48.60M | 93.00M | 73.70M | 116.30M | 201.00M | 269.40M |
Total Debt | 693.00M | 742.80M | 607.00M | 467.40M | 513.10M | 719.60M |
Total Liabilities | 1.47B | 1.53B | 1.45B | 1.33B | 1.23B | 1.39B |
Stockholders Equity | 1.90B | 1.85B | 1.75B | 1.66B | 1.55B | 1.40B |
Cash Flow | ||||||
Free Cash Flow | 105.00M | 13.70M | 42.20M | 90.30M | 123.00M | 15.70M |
Operating Cash Flow | 166.90M | 94.60M | 124.10M | 144.80M | 177.00M | 80.50M |
Investing Cash Flow | -58.40M | -80.40M | -59.30M | -65.70M | 8.40M | -52.50M |
Financing Cash Flow | -339.10M | 7.20M | -107.20M | -175.10M | -253.20M | 62.10M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
71 Outperform | €2.48B | 20.28 | 6.42% | 4.18% | -17.22% | -11.33% | |
63 Neutral | €16.10B | 12.71 | -4.55% | 4.01% | -1.83% | -144.94% | |
€555.59M | 11.70 | 7.71% | 2.24% | ― | ― | ||
€351.25M | 36.31 | 4.63% | ― | ― | ― | ||
€598.65M | 20.30 | 9.31% | 3.75% | ― | ― | ||
€22.84B | 20.94 | 6.70% | 5.15% | ― | ― | ||
€250.19M | 10.25 | 6.53% | 2.09% | ― | ― |